David A. Loegering

4.9k total citations · 2 hit papers
55 papers, 4.0k citations indexed

About

David A. Loegering is a scholar working on Molecular Biology, Physiology and Rheumatology. According to data from OpenAlex, David A. Loegering has authored 55 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 16 papers in Physiology and 14 papers in Rheumatology. Recurrent topics in David A. Loegering's work include Asthma and respiratory diseases (16 papers), Eosinophilic Disorders and Syndromes (14 papers) and Antimicrobial Peptides and Activities (8 papers). David A. Loegering is often cited by papers focused on Asthma and respiratory diseases (16 papers), Eosinophilic Disorders and Syndromes (14 papers) and Antimicrobial Peptides and Activities (8 papers). David A. Loegering collaborates with scholars based in United States, United Kingdom and Canada. David A. Loegering's co-authors include Gerald J. Gleich, Evangelo Frigas, Donald L. Wassom, Gerald J. Gleich, David Steinmuller, Scott H. Kaufmann, Shinji Motojima, A Butterworth, John R. David and Jorge E. Maldonado and has published in prestigious journals such as Science, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

David A. Loegering

55 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytotoxic Properties of the Eosinophil Major Basic Protein

1979 496 citations Gerald J. Gleich, David A. Loegering et al. The Journal of Immunology profile →
Damage to Schistosomula of Schistosoma Mansoni Induced Directly by Eosinophil Major Basic Protein

1979 325 citations Gerald J. Gleich, David A. Loegering et al. The Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David A. Loegering United States	33	1.4k	1.2k	1.1k	974	699	55	4.0k
D A Loegering United States	24	1.4k 1.0×	679 0.5×	1.2k 1.1×	939 1.0×	684 1.0×	36	3.4k
M A Vadas Australia	30	1.3k 0.9×	1.2k 1.0×	545 0.5×	2.9k 3.0×	451 0.6×	48	5.5k
Nives Zimmermann United States	35	2.2k 1.6×	829 0.7×	699 0.6×	2.2k 2.2×	969 1.4×	80	4.5k
Rafeul Alam United States	36	2.1k 1.6×	613 0.5×	514 0.5×	2.1k 2.1×	306 0.4×	64	4.2k
Hisao Tomioka Japan	34	1.3k 0.9×	634 0.5×	777 0.7×	1.8k 1.8×	474 0.7×	140	3.9k
Irma Gigli United States	40	559 0.4×	1.2k 1.0×	597 0.5×	3.1k 3.1×	323 0.5×	131	5.9k
Otto Götze Germany	46	699 0.5×	1.3k 1.0×	372 0.3×	4.2k 4.3×	389 0.6×	132	6.4k
Peter D. Gorevic United States	38	1.2k 0.9×	2.0k 1.6×	1.0k 0.9×	603 0.6×	531 0.8×	106	4.9k
Christoph Heusser Switzerland	41	2.7k 2.0×	1.5k 1.3×	631 0.6×	4.5k 4.6×	442 0.6×	114	8.2k
Carol Bickel United States	24	1.5k 1.1×	382 0.3×	350 0.3×	1.5k 1.5×	273 0.4×	41	3.0k

Countries citing papers authored by David A. Loegering

Since Specialization

Citations

This map shows the geographic impact of David A. Loegering's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Loegering with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Loegering more than expected).

Fields of papers citing papers by David A. Loegering

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Loegering. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Loegering. The network helps show where David A. Loegering may publish in the future.

Co-authorship network of co-authors of David A. Loegering

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Loegering. A scholar is included among the top collaborators of David A. Loegering based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Loegering. David A. Loegering is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gálvez‐Peralta, Marina, Karen S. Flatten, David A. Loegering, et al.. (2014). Context-Dependent Antagonism between Akt Inhibitors and Topoisomerase Poisons. Molecular Pharmacology. 85(5). 723–734. 6 indexed citations

Hendrickson, Andrea E. Wahner, Paul Haluska, Paula A. Schneider, et al.. (2009). Expression of Insulin Receptor Isoform A and Insulin-like Growth Factor-1 Receptor in Human Acute Myelogenous Leukemia: Effect of the Dual-Receptor Inhibitor BMS-536924 In vitro. Cancer Research. 69(19). 7635–7643. 43 indexed citations

Meng, Xue, Michael P. Heldebrant, Karen S. Flatten, et al.. (2009). Protein Kinase Cβ Modulates Ligand-induced Cell Surface Death Receptor Accumulation. Journal of Biological Chemistry. 285(2). 888–902. 15 indexed citations

Kaufmann, Scott H., Sun Hee Lee, X. Wei Meng, et al.. (2008). Apoptosis-associated caspase activation assays. Methods. 44(3). 262–272. 67 indexed citations

Hackbarth, Jennifer S., Marina Gálvez‐Peralta, Nga T. Dai, et al.. (2008). Mitotic Phosphorylation Stimulates DNA Relaxation Activity of Human Topoisomerase I. Journal of Biological Chemistry. 283(24). 16711–16722. 13 indexed citations

Meng, Xue, Sun Hee Lee, Haiming Dai, et al.. (2007). MCL-1 as a Buffer for Proapoptotic BCL-2 Family Members during TRAIL-induced Apoptosis. Journal of Biological Chemistry. 282(41). 29831–29846. 97 indexed citations

Haluska, Paul, Joan M. Carboni, David A. Loegering, et al.. (2005). BMS-554417, an inhibitor of the insulin-like growth factor I receptor and insulin receptor, inhibits proliferation and induces mitochondrial pathway-mediated apoptosis in cancer cell lines. Cancer Research. 65. 1191–1191. 2 indexed citations

Karnitz, Larry M., Karen S. Flatten, Jill M. Wagner, et al.. (2005). Gemcitabine-Induced Activation of Checkpoint Signaling Pathways That Affect Tumor Cell Survival. Molecular Pharmacology. 68(6). 1636–1644. 108 indexed citations

Flatten, Karen S., Nga T. Dai, Benjamin T. Vroman, et al.. (2005). The Role of Checkpoint Kinase 1 in Sensitivity to Topoisomerase I Poisons. Journal of Biological Chemistry. 280(14). 14349–14355. 84 indexed citations

10.

Loegering, David A., Sonnet J.H. Arlander, Jennifer S. Hackbarth, et al.. (2004). Rad9 Protects Cells from Topoisomerase Poison-induced Cell Death. Journal of Biological Chemistry. 279(18). 18641–18647. 33 indexed citations

11.

Johnson, Kenneth L., David A. Loegering, Gerald J. Gleich, & Stephen Naylor. (2003). A modular on‐line three‐dimensional liquid chromatography–tandem mass spectrometry approach to characterization of organelle proteomes. Biomedical Chromatography. 17(2-3). 106–112. 3 indexed citations

12.

Meng, Xue, Joya Chandra, David A. Loegering, et al.. (2003). Central Role of Fas-associated Death Domain Protein in Apoptosis Induction by the Mitogen-activated Protein Kinase Kinase Inhibitor CI-1040 (PD184352) in Acute Lymphocytic Leukemia Cells in Vitro. Journal of Biological Chemistry. 278(47). 47326–47339. 43 indexed citations

13.

Loegering, David A., Yuji Tohda, Jennifer L. Bankers‐Fulbright, et al.. (1999). Discordant and anomalous results among cytotoxicity assays: the confounding properties of eosinophil granule major basic protein on cell viability assays. Journal of Immunological Methods. 227(1-2). 1–15. 8 indexed citations

14.

Bankers‐Fulbright, Jennifer L., Gail M. Kephart, David A. Loegering, et al.. (1998). Sulfonylureas Inhibit Cytokine-Induced Eosinophil Survival and Activation. The Journal of Immunology. 160(11). 5546–5553. 44 indexed citations

15.

Barker, Robert L., et al.. (1990). Cloning and sequence analysis of the human gene encoding eosinophil major basic protein. Gene. 86(2). 285–289. 28 indexed citations

16.

Hamann, Kimm J., Rosa Ten, David A. Loegering, et al.. (1990). Structure and chromosome localization of the human eosinophil-derived neurotoxin and eosinophil cationic protein genes: Evidence for intronless coding sequences in the ribonuclease gene superfamily. Genomics. 7(4). 535–546. 87 indexed citations

17.

Jacoby, David B., Iris F. Ueki, J. H. Widdicombe, et al.. (1988). Effect of Human Eosinophil Major Basic Protein on Ion Transport in Dog Tracheal Epithelium. American Review of Respiratory Disease. 137(1). 13–16. 59 indexed citations

18.

Gleich, Gerald J. & David A. Loegering. (1984). Immunobiology of Eosinophils. Annual Review of Immunology. 2(1). 429–459. 152 indexed citations

19.

Gleich, Gerald J. & David A. Loegering. (1973). Selective stimulation and purification of eosinophils and neutrophils from guinea pig peritoneal fluids.. PubMed. 82(3). 522–8. 32 indexed citations

20.

Gleich, Gerald J., David A. Loegering, & Jorge E. Maldonado. (1973). IDENTIFICATION OF A MAJOR BASIC PROTEIN IN GUINEA PIG EOSINOPHIL GRANULES. The Journal of Experimental Medicine. 137(6). 1459–1471. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact